Want to see ISCO full AI Analyst Report?
International Stem Cell (ISCO) Ratios
45 Followers
International Stem Cell Ratios
ISCO's free cash flow for Q2 2026 was $160.00K. For the 2026 fiscal year, ISCO's free cash flow was decreased by $-7.00K and operating cash flow was $167.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.74 | 0.76 | 0.73 | 0.64 | 0.54 |
| Quick Ratio | 0.41 | 0.51 | 0.47 | 0.34 | 0.27 |
| Cash Ratio | 0.22 | 0.26 | 0.33 | 0.16 | 0.04 |
| Solvency Ratio | -0.02 | -0.00 | 0.01 | -0.01 | -0.05 |
| Operating Cash Flow Ratio | 0.00 | 0.00 | 0.19 | 0.07 | -0.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.27 | 0.10 | -0.44 |
| Net Current Asset Value | $ -5.47M | $ -5.54M | $ -1.76M | $ -6.69M | $ -7.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.77 | 0.74 | 0.78 | 0.83 | 0.82 |
| Debt-to-Equity Ratio | -0.92 | -0.98 | 36.97 | -0.95 | -0.89 |
| Debt-to-Capital Ratio | -11.42 | -42.67 | 0.97 | -17.45 | -7.89 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.19 | -1.32 | 47.70 | -1.14 | -1.08 |
| Debt Service Coverage Ratio | -0.01 | 0.04 | 0.06 | 0.01 | -0.07 |
| Interest Coverage Ratio | -1.77 | -0.47 | -4.77 | -1.45 | -15.01 |
| Debt to Market Cap | 2.98 | 5.22 | 6.97 | 2.31 | 0.80 |
| Interest Debt Per Share | 0.49 | 0.50 | 0.54 | 0.55 | 0.54 |
| Net Debt to EBITDA | -57.08 | 18.38 | 12.82 | 160.59 | -17.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.68% | 58.57% | 59.16% | 60.04% | 59.10% |
| EBIT Margin | -2.93% | -0.70% | 0.10% | -2.40% | -10.74% |
| EBITDA Margin | -0.53% | 1.56% | 2.59% | 0.27% | -3.07% |
| Operating Profit Margin | -2.93% | -0.75% | -8.51% | -2.40% | -26.77% |
| Pretax Profit Margin | -4.59% | -2.30% | -1.68% | -4.05% | -12.53% |
| Net Profit Margin | -4.59% | -2.30% | -1.68% | -5.70% | -14.49% |
| Continuous Operations Profit Margin | -4.59% | -2.30% | -1.68% | -4.05% | -12.53% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 140.79% | 115.68% |
| EBT Per EBIT | 156.55% | 307.35% | 19.76% | 168.88% | 46.80% |
| Return on Assets (ROA) | -8.67% | -4.04% | -2.43% | -9.07% | -21.03% |
| Return on Equity (ROE) | 10.30% | 5.32% | -115.93% | 10.31% | 22.67% |
| Return on Capital Employed (ROCE) | -111.25% | -14.02% | -118.82% | -39.20% | -290.18% |
| Return on Invested Capital (ROIC) | -6.72% | -1.62% | -15.45% | -4.83% | -50.77% |
| Return on Tangible Assets | -10.01% | -4.69% | -2.85% | -10.95% | -26.02% |
| Earnings Yield | -37.30% | -32.12% | -26.40% | -32.34% | -28.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.59 | 8.59 | 13.57 | 10.95 | 8.50 |
| Payables Turnover | 24.01 | 20.24 | 8.74 | 10.15 | 5.78 |
| Inventory Turnover | 2.66 | 3.28 | 2.52 | 2.36 | 2.48 |
| Fixed Asset Turnover | 18.06 | 14.92 | 10.09 | 8.39 | 5.73 |
| Asset Turnover | 1.89 | 1.76 | 1.45 | 1.59 | 1.45 |
| Working Capital Turnover Ratio | -7.93 | -7.45 | -5.22 | -4.52 | -11.48 |
| Cash Conversion Cycle | 150.82 | 135.89 | 130.05 | 151.91 | 127.00 |
| Days of Sales Outstanding | 29.00 | 42.51 | 26.90 | 33.33 | 42.93 |
| Days of Inventory Outstanding | 137.02 | 111.42 | 144.92 | 154.53 | 147.24 |
| Days of Payables Outstanding | 15.20 | 18.04 | 41.77 | 35.95 | 63.18 |
| Operating Cycle | 166.02 | 153.93 | 171.82 | 187.86 | 190.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.12 | 0.04 | -0.17 |
| Free Cash Flow Per Share | -0.00 | -0.02 | 0.11 | 0.04 | -0.17 |
| Dividend Paid and CapEx Coverage Ratio | 0.19 | 0.08 | 11.19 | 30.18 | -28.82 |
| Capital Expenditure Coverage Ratio | 0.19 | 0.08 | 11.19 | 30.18 | -28.82 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.22 | 0.08 | -0.32 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.12 | 0.04 | -0.18 |
| Free Cash Flow Yield | -3.12% | -23.51% | 170.47% | 22.28% | -36.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.80 | -3.11 | -3.79 | -3.09 | -3.54 |
| Price-to-Sales (P/S) Ratio | 0.12 | 0.07 | 0.06 | 0.18 | 0.51 |
| Price-to-Book (P/B) Ratio | -0.28 | -0.17 | 4.39 | -0.32 | -0.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -32.02 | -4.25 | 0.59 | 4.49 | -2.74 |
| Price-to-Operating Cash Flow Ratio | 140.08 | 50.06 | 0.53 | 4.34 | -2.84 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | -0.05 | 0.05 | 0.06 | 0.05 |
| Enterprise Value Multiple | -80.43 | 22.96 | 15.28 | 226.08 | -34.47 |
| Enterprise Value | 3.86M | 3.26M | 3.09M | 4.97M | 7.58M |
| EV to EBITDA | -80.43 | 22.96 | 15.28 | 226.08 | -34.47 |
| EV to Sales | 0.42 | 0.36 | 0.40 | 0.61 | 1.06 |
| EV to Free Cash Flow | -110.30 | -21.31 | 3.65 | 15.49 | -5.65 |
| EV to Operating Cash Flow | 482.58 | 250.83 | 3.32 | 14.98 | -5.85 |
| Tangible Book Value Per Share | -0.59 | -0.58 | -0.09 | -0.67 | -0.71 |
| Shareholders’ Equity Per Share | -0.51 | -0.49 | 0.01 | -0.56 | -0.59 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.14 | 1.14 | 0.97 | 1.02 | 0.92 |
| Net Income Per Share | -0.05 | -0.03 | -0.02 | -0.06 | -0.13 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.41 | 1.16 |
| Interest Burden | 1.57 | 3.27 | -16.38 | 1.69 | 1.17 |
| Research & Development to Revenue | 0.08 | 0.07 | 0.07 | 0.06 | 0.10 |
| SG&A to Revenue | 0.51 | 0.52 | 0.45 | 0.41 | 0.57 |
| Stock-Based Compensation to Revenue | 0.03 | 0.05 | 0.06 | 0.05 | 0.09 |
| Income Quality | -0.02 | -0.06 | -7.09 | -1.00 | 1.44 |
Currency in USD
